Start your single-user one-year subscription (250 issues) FDAnews for only $1,895.Īlso available: Take advantage of our multi-user and site licenses of FDAnews, so you’ll have the most-informed workforce! Contact James DeFalco, Sales Director at or +1 703.538.7638 to receive a custom quote. Start your subscription to FDAnews - the trusted source for drug and device insights - today. It makes sense of everything successful drug and device manufacturers must know and do, delivering the news, analysis and interpretation of industry changes you need to stay in compliance and thrive. Daily posts of breaking headlines and premium stories throughout the day on įDAnews delivers precisely what you need to know each business day.Excerpts of best-selling FDAnews webinar and book content.Original columns from thought leaders and former FDA officials on trending topics.In-depth exposés that take a deep dive into essential pharmaceutical and device issues.Reports and perspective on Form 483s, warning letters, recalls, FDA policy notices and other reports.Global enforcement and supply chain trends If your narcolepsy started due to or was aggravated by your military service in some way, you may be eligible for VA disability benefits.The classic tetrad for narcolepsy consists of excessive daytime sleepiness (EDS), cataplexy, sleep paralysis, and hypnagogic hallucinations. FDA inspection policies, practices and enforcement activities Narcolepsy is a chronic sleep disorder caused by a dysfunction of the central nervous system’s sleep-wake regulation.Quality and GMP regulatory policies and developments.FDA budgets and spending, including proposals and approvals by Congress and the President.Company mergers and technology developments.Draft and final guidances from the FDA and other regulatory agencies.Best practices in regulatory compliance and the pathways to approval.Written and reported by FDAnews’ team of experienced industry journalists and subject matter experts, each issue delivers coverage of the regulatory, legislative and business changes affecting the global drug and device industry.Įach business day, FDAnews provides valuable insights into: FDAnews delivers what you need to know each business day. These two publications have recently merged to become FDAnews, a trusted one-stop destination for drug and device insights. The trusted source for drug and device insightsĬompliance - and business success - are rooted in an understanding of the top pharma, medical device and regulatory developments.įor decades, top drug and device manufacturers have relied on FDAnews’ insightful coverage with two of the industry’s most-trusted publications: Drug Industry Daily and Device Daily Bulletin Premium.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |